ReviewFrontiers in immunology2021

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma.

Kimberly Loo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.